Ireland
--:--IST
Latest
Clinical Trials in Israel / NCT06730074
Recruiting Not applicable

A Novel Robotic System for Motor-cognitive Exercise for Patients With Parkinson's Disease

NCT06730074 · tracked via the Priya Life Science Israel tracker
Phase
Not applicable
Started
2024-12-12
Last updated
2024-12-17

Condition(s) studied

Parkinson Disease, Idiopathic

Investigational drug(s) / intervention(s)

Using a gamified rehabilitation system in a sitting position involving robots and music for the benefit of individuals with Parkinson's disease (PD)

Using a gamified rehabilitation system in a sitting position involving robots and music for the benefit of individuals with Parkinson's disease (PD): This is the first socially assistive robotic platform developed specifically for people with PD. If successful, this platform could be incorporated into the clinical toolbox at Adi Negev and other centres.

Study summary

The objective of this study is to test a gamified rehabilitation system in a sitting position involving robots and music for the benefit of individuals with Parkinson's disease (PD). This pilot experiment will involve the collection of both subjective user evaluation measures and objective motor and cognitive measures.

Eligibility

Sex
ALL
Min age
50 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria: * Signing the informed consent form * Men and women in ages 50-75 * Hebrew speakers * Have Idiopathic Parkinson's disease * Hoehn and Yahr 3 and below * Moca test 23 and above Exclusion Criteria: * Patients with Parkinson's plus syndromes * PD patients who suffer from unrelated neurological symptoms. * Orthopedic problems of the upper limb * Recent surgery conducted on the upper limb * Uncorrected vision problems * Uncorrected severe hearing loss

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Adi Negev Ofakim South Recruiting

More Adi Negev-Nahalat Eran trials in Israel

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06730074 on ClinicalTrials.gov ↗ ← All trials in Israel